193 related articles for article (PubMed ID: 34822071)
1. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
[TBL] [Abstract][Full Text] [Related]
2. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.
Chen M; Li S
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065
[No Abstract] [Full Text] [Related]
3. The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis.
Dong F; Yang G; Pan HW; Huang WH; Jing LP; Liang WK; Zhang N; Zhang BH; Wang M; Liu Y; Zhang LJ; Zhang SH; Li H; Chen C; Nie LH; Jing CX
Acta Diabetol; 2014 Oct; 51(5):691-703. PubMed ID: 25005490
[TBL] [Abstract][Full Text] [Related]
4. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
Jin P; Xiang B; Huang G; Zhou Z
J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
[TBL] [Abstract][Full Text] [Related]
6. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
Fang M; Huang W; Mo D; Zhao W; Huang R
Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
[TBL] [Abstract][Full Text] [Related]
7. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
Zhao JJ; Wang D; Yao H; Sun DW; Li HY
World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T-lymphocyte antigen-4 +49A/G polymorphisms in Sudanese adults with type 1 diabetes and latent autoimmune diabetes.
Alshareef SA; Omar SM; Hamdan HZ; Adam I
BMC Res Notes; 2019 Nov; 12(1):769. PubMed ID: 31771625
[TBL] [Abstract][Full Text] [Related]
10. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
[TBL] [Abstract][Full Text] [Related]
11. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
[TBL] [Abstract][Full Text] [Related]
12. Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: Evidence from a meta-analysis.
Zhang S; Yang X; Wang W
Genomics; 2020 Mar; 112(2):1889-1896. PubMed ID: 31698031
[TBL] [Abstract][Full Text] [Related]
13. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
[TBL] [Abstract][Full Text] [Related]
14. Association between
Zhou C; Gao S; Yuan X; Shu Z; Li S; Sun X; Xiao J; Liu H
Aging (Albany NY); 2021 Aug; 13(15):19397-19414. PubMed ID: 34339393
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.
Li J; Wang W; Sun Y; Zhu Y
World J Surg Oncol; 2020 Mar; 18(1):55. PubMed ID: 32178688
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis.
Ni J; Qiu LJ; Zhang M; Wen PF; Ye XR; Liang Y; Pan HF; Ye DQ
Endocr Res; 2014; 39(4):180-8. PubMed ID: 24697361
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 promoter polymorphisms are associated with latent autoimmune diabetes in adults.
Douroudis K; Prans E; Uibo R
Hum Immunol; 2009 Nov; 70(11):921-4. PubMed ID: 19735686
[TBL] [Abstract][Full Text] [Related]
18. Relationship of genetic polymorphisms in
Yu Y; Qu J; Zhou C; You G
Epidemiol Infect; 2019 Dec; 147():e313. PubMed ID: 31801640
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis.
Yang XC; Fujino M; Cai SJ; Li SW; Liu C; Li XK
J Immunol Res; 2017; 2017():5295164. PubMed ID: 28642883
[TBL] [Abstract][Full Text] [Related]
20. Association between rs3087243 and rs231775 polymorphism within the cytotoxic T-lymphocyte antigen 4 gene and Graves' disease: a case/control study combined with meta-analyses.
Tu Y; Fan G; Dai Y; Zeng T; Xiao F; Chen L; Kong W
Oncotarget; 2017 Dec; 8(66):110614-110624. PubMed ID: 29299173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
